How Does Smoking Cause Lung Cancer, Explained

Smoking causes lung cancer through a chain of biological damage that unfolds over years, not through any single event. Cigarette smoke delivers dozens of known carcinogens directly into lung tissue, where they chemically bind to DNA, corrupt critical genes, cripple the lung’s self-cleaning mechanisms, and provoke chronic inflammation that fuels abnormal cell growth. No single one of these mechanisms is “the” cause; they work in concert, each making the next more dangerous. The process helps explain why lung cancer typically takes decades to develop in smokers and why, even after quitting, the risk lingers.

A Cocktail of Carcinogens, Not Just One Villain

Cigarette smoke is not a simple substance. Researchers have classified the carcinogens in tobacco into at least ten chemical subgroups, including hydrocarbons, nitrosamines, aldehydes, amines, and inorganic compounds, among others.¹ Of the hundreds of chemicals in smoke, roughly 20 have been shown convincingly to cause lung tumors in lab animals or humans. Two groups stand out as especially important: polycyclic aromatic hydrocarbons (PAHs) and a tobacco-specific nitrosamine called NNK.² These are the chemicals that do the heaviest lifting when it comes to initiating cancer, though they don’t work alone. Health agencies have focused monitoring efforts on three priority chemical categories in smoke: tobacco-specific nitrosamines, PAHs, and volatile organic compounds.³

How Carcinogens Wreck Your DNA

Once inhaled, these chemicals don’t just irritate lung tissue. They get absorbed into cells, where the body’s own enzymes try to break them down for elimination. Ironically, this metabolic processing often converts relatively inert compounds into highly reactive forms that latch onto DNA, forming what scientists call DNA adducts. These adducts are essentially chemical scars on the genetic code, and they are considered a central step in how smoking triggers cancer. Researchers have identified adducts derived from aromatic amines, PAHs, nitrosamines, aldehydes, and several other carcinogen classes in the DNA of smokers.⁴

Cigarette smoke also ramps up the activity of an enzyme called aryl hydrocarbon hydroxylase, which processes benzo[a]pyrene, one of the best-studied PAHs. This enzyme activation effectively increases the dose of reactive carcinogen that reaches DNA.⁵ Think of it as the body accidentally sharpening the weapon the smoke brought through the door.

When DNA adducts aren’t repaired before a cell divides, they become permanent mutations. One of the most telling clues comes from the p53 gene, a crucial tumor suppressor that acts as a kind of emergency brake on runaway cell growth. In lung tumors from smokers, a specific type of mutation called a G-to-T transversion shows up about three times more often than in nonsmokers’ tumors (roughly 30% versus 10%). This pattern is statistically unmistakable and matches the kind of damage that PAHs and nitrosamines are known to cause, reinforcing that these mutations come directly from smoke-related DNA damage rather than from some preexisting defect.⁶

Your Lungs’ Self-Cleaning System Gets Sabotaged

Healthy lungs are lined with tiny hair-like structures called cilia that beat in coordinated waves, pushing mucus and trapped particles up toward the throat where they can be coughed out or swallowed. This system, called mucociliary clearance, is one of the body’s first lines of defense against inhaled toxins. Smoking attacks it on multiple fronts.

In smokers, airway cilia are physically shorter than in nonsmokers. Because cilia need to extend through the thin layer of fluid lining the airways to make contact with the mucus layer above, even a modest reduction in length means many cilia can no longer reach the mucus to push it along. Depending on the depth of the airway fluid, smokers lose an estimated 18 to 38% of their effective cilia function due to this shortening alone.⁷ On top of that, repeated smoke exposure disrupts the genes responsible for cilia formation and function, altering how fast the remaining cilia beat and reducing the proteins they need to work properly.⁸

The practical consequence is that carcinogens in smoke stay in contact with lung tissue longer than they would in a nonsmoker. If your lungs can’t clear the toxic material efficiently, every cigarette gives those chemicals more time to damage cells.

Chronic Inflammation as a Tumor Promoter

Smoke doesn’t just mutate cells; it also creates a persistently inflamed environment in the lungs that helps mutated cells survive and multiply. Chronic inflammation recruits immune cells like macrophages and neutrophils into the lung tissue, but instead of resolving the threat, the inflammation becomes self-sustaining. The recruited cells generate reactive oxygen species that cause additional DNA damage and release signaling molecules that push nearby cells to divide faster.⁹

Animal experiments have demonstrated this promotion effect directly. In mice exposed to tobacco smoke after treatment with a chemical carcinogen, tumors developed more readily than in unexposed animals. The tumor-promoting effect was traced to specific inflammatory signaling pathways. When researchers blocked one of these pathways in immune cells, the smoke’s ability to promote tumors was largely eliminated, confirming that the inflammation itself, not just the carcinogens, was driving tumor growth forward.¹⁰

Smoke also reshapes the immune landscape within the lung in ways that favor cancer. Cigarette smoke pushes macrophages toward a state (called the M2 phenotype) that suppresses immune responses against tumors rather than attacking them. These M2-type macrophages are more resistant to smoke’s toxic effects and harder to switch back to a tumor-fighting state, so smokers’ lungs accumulate immune cells that essentially protect growing tumors instead of destroying them.¹¹ Separately, smoking causes broader DNA damage and immune dysfunction in the lung that collectively contribute to both the initiation and progression of cancer.¹²

Silencing Genes Without Changing the Code

Beyond directly mutating DNA, cigarette smoke also changes how genes are read by the cell, without altering the genetic sequence itself. This happens through a process called DNA methylation, where chemical tags get added to gene promoters and effectively switch them off. When tumor suppressor genes get silenced this way, the cell loses important safety mechanisms that would normally prevent uncontrolled growth.

Studies have shown that tobacco smoke can induce methylation of tumor suppressor genes even before any cancer is detectable. For example, the NISCH gene, which helps regulate cell signaling, showed promoter methylation after exposure to both mainstream and sidestream smoke in laboratory cell lines.¹³ A meta-analysis of lung cancer patients found that hypermethylation of p16, another important tumor suppressor, was about twice as common in smokers as in nonsmokers with the same type of lung cancer.¹⁴ Researchers have also found that smoking increases methylation in the promoter region of LEF1-AS1, a gene involved in cell regulation, by an average of about 20% in smokers compared to nonsmokers.¹⁵

These epigenetic changes are insidious because they can accumulate quietly over years and may affect many genes simultaneously. A cell with enough silenced tumor suppressors and enough accumulated mutations is well on its way toward becoming cancerous.

Field Cancerization and Stem Cell Takeover

One of the more striking recent findings is that carcinogen exposure doesn’t just damage random scattered cells. It triggers a competitive process among the basal stem cells that line the airways. Normally, these stem cells divide and replace damaged surface cells in an orderly way. But after carcinogen exposure, a few heavily mutated clones begin outcompeting their neighbors, expanding aggressively and colonizing large stretches of the airway. This phenomenon, known as field cancerization, means that by the time a visible tumor appears, much of the surrounding airway may already be dominated by abnormal clones. Researchers have confirmed this in human patients, finding clonally related precancerous lesions spread across different regions of the same patient’s airways.¹⁶

This helps explain a frustrating clinical reality: surgeons can remove a lung tumor, but the patient sometimes develops a new cancer in a different part of the lung. The soil was already seeded across a wide area.

Not All Lung Cancers Are Equally Linked to Smoking

Lung cancer is not one disease. There are several major types, and smoking does not raise the risk equally across all of them. A meta-analysis found that while all major types were significantly associated with cigarette smoking, the association was strongest with squamous cell carcinoma and small cell carcinoma, and somewhat weaker for adenocarcinoma.¹⁷ In one study, current smokers had roughly 19 times the odds of squamous cell carcinoma and about 14 times the odds of small cell carcinoma compared to nonsmokers, while the odds for adenocarcinoma were elevated about 8-fold.¹⁸

Adenocarcinoma, now the most common form of lung cancer overall, occurs with meaningful frequency in nonsmokers too. That does not mean smoking doesn’t cause adenocarcinoma. It does. But the mechanism appears to involve somewhat different pathways than the types most tightly linked to smoking, and other risk factors like radon exposure, air pollution, and genetic predisposition play a larger relative role in adenocarcinoma.¹⁹

Why Some Smokers Never Get Lung Cancer

A common objection to the smoking-cancer link is the existence of lifelong smokers who never develop the disease. This observation is real but has a straightforward explanation: people vary in how efficiently their bodies activate and detoxify carcinogens. The enzymes that process smoke chemicals come in different genetic variants, and certain combinations leave a person more or less vulnerable.

Smokers who lack a functional copy of the GSTM1 gene, which codes for a detoxification enzyme, appear to have an imbalance: their cells are better at converting carcinogens like benzo[a]pyrene into their reactive form but worse at neutralizing them. This imbalance may explain the increased lung cancer susceptibility observed in smokers carrying that genetic variant.²⁰ More broadly, the large number of carcinogen-activating and detoxifying enzymes in the body, combined with the complexity of tobacco smoke itself, means that variations across many genes can shift an individual’s cancer risk substantially in either direction.²¹ These genetic variants can also interact with each other and with sex-linked differences, creating a web of susceptibility rather than a single on-off switch.²²

Another striking example involves the enzyme that metabolizes nicotine itself. A meta-analysis found that people with no functional copies of the gene for this enzyme (CYP2A6) had more than a 60% reduction in lung cancer incidence compared to those with normal copies. People who were predicted to be poor metabolizers of nicotine had about a 30% lower cancer risk.²³ The likely explanation is that slow nicotine metabolizers tend to smoke less intensely because the nicotine stays active in their blood longer, reducing their overall carcinogen exposure.

Nicotine Itself Is Not a Carcinogen, But It Isn’t Innocent

A widespread misconception is that nicotine is the cancer-causing ingredient in cigarettes. It is not. Nicotine is the addictive component, and it does not directly damage DNA the way PAHs or nitrosamines do. However, calling it harmless to cancer risk would be wrong. Nicotine promotes cell proliferation and stimulates the growth of new blood vessels, a process called angiogenesis. Tumors need a blood supply to grow, and nicotine helps provide one. It also encourages a cellular behavior that makes cancers more likely to spread.²⁴

In mouse models of lung cancer, nicotine at concentrations comparable to what smokers experience accelerated tumor growth and was associated with increased blood vessel formation within the tumors.²⁵ So while nicotine doesn’t start the fire, it fans the flames once a tumor begins forming. This distinction matters for people considering nicotine replacement therapies to quit smoking: patches and gum are vastly safer than cigarettes, but the nicotine they deliver is not biologically inert with respect to cancer progression.

Secondhand Smoke Follows the Same Playbook

The mechanisms described above apply not just to smokers but to anyone regularly breathing in someone else’s smoke. Secondhand smoke contains the same carcinogens, just in lower concentrations. A large meta-analysis pooling data from over 80 studies found that never-smokers exposed to secondhand smoke had about a 24% higher risk of lung cancer compared to unexposed never-smokers.²⁶ The risk appears to be higher for people whose exposure began in childhood or young adulthood: those first exposed before age 25 had a higher lung cancer risk than those whose exposure started later.²⁷

The lower concentration of carcinogens in secondhand smoke explains why the risk increase is modest compared to active smoking but still real and consistent across studies. The DNA damage, inflammatory signaling, and impaired clearance mechanisms are the same; only the dose differs.

When Smoking Meets Other Carcinogens

Smoking rarely operates in a vacuum. Many smokers are also exposed to workplace chemicals, radon in homes, or air pollution, and these exposures can interact with smoking in ways that multiply risk beyond what you’d expect from either alone. The best-studied example is asbestos. A meta-analysis examining how asbestos and smoking interact found that the combined effect fits a more-than-additive model, meaning the joint risk is greater than what you’d get by simply adding the two individual risks together.²⁸ Other analyses have described this interaction as roughly multiplicative.²⁹ The exact mathematical model is debated, but the practical message is the same: if you smoke and are exposed to asbestos, your risk is not just a little higher but dramatically higher than from either exposure alone. And the elevated risk persists for up to 20 years after quitting, compared to someone who never smoked.³⁰

Vaping Combined with Smoking

A growing question is whether e-cigarettes change the picture. A recent case-control study looking at early-onset lung cancer (diagnosed before age 50) found that smoking alone carried about five times the odds of lung cancer compared to people who neither smoked nor vaped. But people who both vaped and smoked had roughly 14 times the odds, nearly three times higher than smoking alone. For adenocarcinoma specifically, the gap was even wider: dual users had about 15 times the odds, compared to four times for smokers who did not vape.³¹ This is a single study and the findings need replication, but the numbers are striking enough to warrant attention, especially among younger adults who may view vaping as a safe complement to reduced smoking.

Smoking and the Lung Microbiome

An area of growing research interest is how smoking alters the community of microorganisms living in the lungs and airways. The lung was once thought to be sterile, but it hosts a resident microbial community that appears to play a role in immune regulation and inflammation. Smoking has been shown to shift the composition of the oral, lung, and gut microbiome, and these shifts have been linked to a range of diseases including chronic obstructive pulmonary disease and several cancers.³² How exactly a disrupted lung microbiome contributes to cancer initiation or progression is still being worked out. One hypothesis is that the altered microbial community promotes chronic low-grade inflammation, reinforcing the inflammatory signaling that smoke already triggers through chemical damage. Another is that certain microbial metabolites produced by an imbalanced community can directly affect epithelial cell behavior. The research is early enough that no firm causal claims can be made, but the microbiome is increasingly seen as another piece of the puzzle connecting smoking to cancer.